Efficacy of mirabegron for overactive bladder with human T cell lymphotropic virus‐1 associated myelopathy

OBJECTIVE: Mirabegron is widely considered as an effective and safe drug for patients with overactive bladder (OAB). However, there is no evidence regarding the efficacy of mirabegron in human T cell lymphotropic virus‐1 (HTLV‐1)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuo, Tomohiro, Miyata, Yasuyoshi, Nakamura, Tatsufumi, Satoh, Katsuya, Sakai, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Asia Pty Ltd 2018
Materias:
Original Articles ‐ Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379193/
https://www.ncbi.nlm.nih.gov/pubmed/29473309
http://dx.doi.org/10.1111/luts.12218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379193/
https://www.ncbi.nlm.nih.gov/pubmed/29473309
http://dx.doi.org/10.1111/luts.12218

Ejemplares similares